Swiftalyn Wart Remover

Manufacturer
Shenzhen Peruidaishi Technology Co., Ltd.
Effective date
2024-03-13
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
legacy-cache
Hydrated at
2026-08-01 21:08:49

Label at a glance#

ProductSwiftalyn Wart Remover
Active ingredientSALICYLIC ACID
Label structure13 sections

Dosage and administration

May soak the wart in warm water for 5 minutes. Dry the area thoroughly. Apply a small amount at a time with a cotton swab or brush to sufficiently cover each wart. Let dry. Repeat this procedure once or twice daily as needed until the wart is removed.

Storage and handling

Seal the bottle and place it in a cool and dry place.

Label contents#

Full prescribing information#

Active Ingredient

OTC - ACTIVE INGREDIENT SECTION

Salicylic Acid 5%

Purpose

OTC - PURPOSE SECTION

Wart remover

Use

INDICATIONS & USAGE SECTION

For the removal of common warts. The common wart is easily recognized by the rough ‘cauliflower-like’ appearance of the surface.”
For the removal of plantar warts on the bottom of the foot. The plantar wart is recognized by its location only on the bottom of the foot, its tenderness, and the interruption of the footprint pattern.

Warnings

WARNINGS SECTION

For external use only.
Only use on affected area.
Keep away from fire and flame.

Do not use

OTC - DO NOT USE SECTION

Do not use on moles, birthmarks, warts with hair growing from them, genital warts, or warts on the face or mucous membranes.
Do not use this product on irritated skin, on any area that is infected or reddened,
Do not use this product if you are a diabetic, or if you have poor blood circulation.

When Using

OTC - WHEN USING SECTION

Avoid contact with eyes. If the product gets into the eye, flush with water for 15 mintutes. Cap the bottle tightly.

Ask Doctor

OTC - ASK DOCTOR SECTION

If discomfort persists, please stop use and see your doctor.

Stop Use

OTC - STOP USE SECTION

If you are a diabetic, or if you have poor blood circulation

Keep Oot Of Reach Of Children

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep it away from children. Seal the bottle and place it in a cool and dry place.

Directions

DOSAGE & ADMINISTRATION SECTION

May soak the wart in warm water for 5 minutes. Dry the area thoroughly.
Apply a small amount at a time with a cotton swab or brush to sufficiently cover each wart. Let dry. Repeat this procedure once or twice daily as needed until the wart is removed.

Other information

STORAGE AND HANDLING SECTION

Seal the bottle and place it in a cool and dry place.

Inactive ingredients

INACTIVE INGREDIENT SECTION

Water, Alcohol Denat, Propylene Glycol, Angelica Dahurica Root, Asiatic Acid

Questions

OTC - QUESTIONS SECTION

Email at: swiftalyn@gmail.com

PRINCIPAL DISPLAY PANEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

11

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
84048-006SWIFTALYN WART REMOVER (WART REMOVER) LIQUID [SHENZHEN PERUIDAISHI TECHNOLOGY CO., LTD.]1Unmatched20240314_1383fefd-100b-805e-e063-6394a90a4714.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 8 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
84048-00684048-006-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 6 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
36581518-2ef5-00b4-e063-6294a90ab7f91383fefd-100b-805e-e063-6394a90a47142025-05-30WarningsExact identifier
spl set id: 1383fefd-100b-805e-e063-6394a90a4714

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.